Is ERNA or EVGN more undervalued in 2026?

CirclFi compares Ernexa Therapeutics Inc. (ERNA) and Evogene Ltd. (EVGN) using 13 institutional-grade valuation models. ERNA has a Quality of Company score of 4.9/10 while EVGN scores 1.9/10.

Which is a better buy — ERNA or EVGN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ERNA and EVGN valuations compare?

ERNA at $11.66 and EVGN at $0.72 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ERNA vs EVGN Valuation Comparison 2026 — Intrinsic Value Analysis

ERNA

Biotechnology

Ernexa Therapeutics Inc.

Quality

4.9

out of 10

Value Trap

LOW

Price

$11.66

Last close

Models

9/13

Active

EVGN

Biotechnology

Evogene Ltd.

Quality

1.9

out of 10

Value Trap

SAFE

Price

$0.72

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	ERNA Fair Value	ERNA Upside	EVGN Fair Value	EVGN Upside
Bayesian DCF	Intrinsic	$3.80	-67.4%	$0.19	-73.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.01	-92.7%	$1.29	+80.4%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$2.31	-80.2%	$4.11	+475.3%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ERNA vs EVGN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ERNA vs EVGN — Which Stock Is More Undervalued?

ERNA scores higher with a 4.9/10 quality rating vs EVGN's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Ernexa Therapeutics Inc. (ERNA) and Evogene Ltd. (EVGN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ERNA currently trades at $11.66 with a QOC of 4.9/10, while EVGN trades at $0.72 with a QOC of 1.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).